Currus Biologics
About:
Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
Website: https://www.currusbio.com/
Top Investors: Brandon Capital, Uniseed, Brandon BioCatalyst, Medical Research Commercialisation Fund (MRCF)
Description:
Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
Total Funding Amount:
10M AUD
Headquarters Location:
Melbourne, Victoria, Australia
Founded Date:
2020-01-01
Contact Email:
info(AT)currusbio.com
Founders:
Samantha Cobb
Number of Employees:
1-10
Last Funding Date:
2024-05-07
IPO Status:
Private
Industries:
© 2025 bioDAO.ai